Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

Search life-sciences literature (45,100,050 articles, preprints and more)

Search results

1-25 of 298 results

Sort by:

Relevance ^{Relevance: This is determined based on a ranking of criteria including term frequency, rarity of term, recency of article, whether there is a Title or Author field match, etc.}

Times cited

Date

1 2 3 Next ...

Real-world impact of pembrolizumab availability for deficient mismatch repair metastatic colorectal cancer.
Loft M, Wong V, Kosmider S, Wong R, Shapiro J, Hong W, Jennens R, Tie J, Caird S, Steel S, Lee B, Nott L, Khattak MA, Lim S, Chong G, Hayes T, Underhill C, McLachlan SA, Rainey N, [...] Gibbs P
Intern Med J, 18 Nov 2024
Cited by: 0 articles | PMID: 39555636
Add to export list
Stage-Specific Guideline Concordant Treatment Impacts on Survival in Nonsmall Cell Lung Cancer: A Novel Quality Indicator.
Tissera S, Billah B, Brand M, Karim MN, Antippa P, Blum R, Caldecott M, Conron M, Faisal W, Harden S, Olesen I, Parente P, Richardson G, Samuel E, See K, Underhill C, Wright G, Zalcberg J, Stirling RG
Clin Lung Cancer, S1525-7304(24)00191-8, 24 Aug 2024
Cited by: 0 articles | PMID: 39304361
Add to export list
BRCA1 secondary splice-site mutations drive exon-skipping and PARP inhibitor resistance.
Nesic K, Krais JJ, Wang Y, Vandenberg CJ, Patel P, Cai KQ, Kwan T, Lieschke E, Ho GY, Barker HE, Bedo J, Casadei S, Farrell A, Radke M, Shield-Artin K, Penington JS, Geissler F, Kyran E, Betsch R, [...] Wakefield MJ
Mol Cancer, 23(1):158, 05 Aug 2024
Cited by: 1 article | PMID: 39103848 | PMCID: PMC11299415
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Timing of whole genome duplication is associated with tumor-specific MHC-II depletion in serous ovarian cancer.
Burdett NL, Willis MO, Pandey A, Twomey L, Alaei S, Australian Ovarian Cancer Study Group, Bowtell DDL, Christie EL
Nat Commun, 15(1):6069, 18 Jul 2024
Cited by: 2 articles | PMID: 39025846 | PMCID: PMC11258338
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Phase 1a dose escalation study of ivonescimab (AK112/SMT112), an anti-PD-1/VEGF-A bispecific antibody, in patients with advanced solid tumors.
Frentzas S, Austria Mislang AR, Lemech C, Nagrial A, Underhill C, Wang W, Wang ZM, Li B, Xia Y, Coward JIG
J Immunother Cancer, 12(4):e008037, 19 Apr 2024
Cited by: 2 articles | PMID: 38642937 | PMCID: PMC11033648
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Exploring management and outcomes of elderly patients with glioblastoma using data from two randomised trials (GEINO1401/EX-TEM).
Gately L, Mesía C, Sepúlveda JM, Del Barco S, Pineda E, Gironés R, Fuster J, Dumas M, Gill S, Navarro LM, Herrero A, Dowling A, de Las Peñas R, Vaz MA, Alonso M, Lwin Z, Harrup R, Peralta S, Long A, [...] Balana C
J Neurooncol, 168(2):299-306, 17 Apr 2024
Cited by: 1 article | PMID: 38630385
Add to export list
RESILIENT Part 2: A Randomized, Open-Label Phase III Study of Liposomal Irinotecan Versus Topotecan in Adults With Relapsed Small Cell Lung Cancer.
Spigel DR, Dowlati A, Chen Y, Navarro A, Yang JC, Stojanovic G, Jove M, Rich P, Andric ZG, Wu YL, Rudin CM, Chen H, Zhang L, Yeung S, Benzaghou F, Paz-Ares L, Bunn PA, RESILIENT Trial Investigators
J Clin Oncol, 42(19):2317-2326, 22 Apr 2024
Cited by: 2 articles | PMID: 38648575 | PMCID: PMC11210946
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Decentralized Clinical Trials as a New Paradigm of Trial Delivery to Improve Equity of Access.
Underhill C, Freeman J, Dixon J, Buzza M, Long D, Burbury K, Sabesan S, McBurnie J, Woollett A
JAMA Oncol, 10(4):526-530, 01 Apr 2024
Cited by: 1 article | PMID: 38358756
Add to export list
A gut microbial signature for combination immune checkpoint blockade across cancer types.
Gunjur A, Shao Y, Rozday T, Klein O, Mu A, Haak BW, Markman B, Kee D, Carlino MS, Underhill C, Frentzas S, Michael M, Gao B, Palmer J, Cebon J, Behren A, Adams DJ, Lawley TD
Nat Med, 30(3):797-809, 01 Mar 2024
Cited by: 5 articles | PMID: 38429524 | PMCID: PMC10957475
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Correction to: A combined analysis of two prospective randomised studies exploring the impact of extended post-radiation temozolomide on survival outcomes in newly diagnosed glioblastoma.
Gately L, Mesía C, Sepúlveda JM, Del Barco S, Pineda E, Gironés R, Fuster J, Hong W, Dumas M, Gill S, Navarro LM, Herrero A, Dowling A, de Las Peñas R, Vaz MA, Alonso M, Lwin Z, Harrup R, Peralta S, [...] Balana C
J Neurooncol, 166(3):417-418, 01 Feb 2024
Cited by: 2 articles | PMID: 38289531
Add to export list
A Population-Based Family Case-Control Study of Sun Exposure and Follicular Lymphoma Risk.
Odutola MK, van Leeuwen MT, Bruinsma F, Turner J, Hertzberg M, Seymour JF, Prince HM, Trotman J, Verner E, Roncolato F, Opat S, Lindeman R, Tiley C, Milliken ST, Underhill CR, Benke G, Giles GG, Vajdic CM
Cancer Epidemiol Biomarkers Prev, 33(1):106-116, 01 Jan 2024
Cited by: 1 article | PMID: 37831120 | PMCID: PMC10774741
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
A combined analysis of two prospective randomised studies exploring the impact of extended post-radiation temozolomide on survival outcomes in newly diagnosed glioblastoma.
Gately L, Mesía C, Sepúlveda JM, Del Barco S, Pineda E, Gironés R, Fuster J, Hong W, Dumas M, Gill S, Navarro LM, Herrero A, Dowling A, de Las Peñas R, Vaz MA, Alonso M, Lwin Z, Harrup R, Peralta S, [...] Balana C
J Neurooncol, 166(3):407-415, 28 Dec 2023
Cited by: 1 article | PMID: 38153582
Add to export list
Changing high-risk asthma in Memphis through partnership: Results from the CHAMP program.
Steppe S, Stokes DC, Underhill C, Winders TA, Gardner DD, Michael CF
Ann Allergy Asthma Immunol, 132(4):485-490.e2, 10 Dec 2023
Cited by: 0 articles | PMID: 38081410
Add to export list
Small-scale mutations are infrequent as mechanisms of resistance in post-PARP inhibitor tumour samples in high grade serous ovarian cancer.
Burdett NL, Willis MO, Pandey A, Fereday S, AOCS Study Group, DeFazio A, Bowtell DDL, Christie EL
Sci Rep, 13(1):21884, 11 Dec 2023
Cited by: 2 articles | PMID: 38072854 | PMCID: PMC10711013
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
A phase II trial of nivolumab followed by ipilimumab and nivolumab in advanced non-clear-cell renal cell carcinoma.
Conduit C, Davis ID, Goh JC, Kichenadasse G, Gurney H, Harris CA, Pook D, Krieger L, Parnis F, Underhill C, Adams D, Roncolato F, Joshua A, Ferguson T, Prithviraj P, Morris M, Harrison M, Begbie S, Hovey E, [...] UNISoN Investigators
BJU Int, 133 Suppl 3:57-67, 20 Nov 2023
Cited by: 0 articles | PMID: 37986556
Add to export list
Telehealth in oncology: a cost analysis to evaluate the financial impact of implementing regional trial hubs within a phase 3 cancer clinical trial.
Alexander M, Collins I, Abraham P, Underhill C, Harris S, Torres J, Sharma S, Solomon B, Tran-Duy A, Burbury K
Intern Med J, 53(12):2346-2349, 01 Dec 2023
Cited by: 0 articles | PMID: 38130050 | PMCID: PMC10946773
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Risk-Directed Ambulatory Thromboprophylaxis in Lung and Gastrointestinal Cancers: The TARGET-TP Randomized Clinical Trial.
Alexander M, Harris S, Underhill C, Torres J, Sharma S, Lee N, Wong H, Eek R, Michael M, Tie J, Rogers J, Heriot AG, Ball D, MacManus M, Wolfe R, Solomon BJ, Burbury K
JAMA Oncol, 9(11):1536-1545, 01 Nov 2023
Cited by: 6 articles | PMID: 37733336 | PMCID: PMC10514890
Add to export list Free full text in Europe PMC
Patient and healthcare professional acceptability of pharmacogenetic screening for DPYD and UGT1A1: A cross sectional survey.
Glewis S, Krishnasamy M, Lingaratnam S, Harris S, Underhill C, Georgiou C, Warren M, Campbell R, IJzerman M, Fagery M, Campbell I, Martin JH, Tie J, Alexander M, Michael M
Clin Transl Sci, 16(12):2700-2708, 31 Oct 2023
Cited by: 1 article | PMID: 37877594 | PMCID: PMC10719470
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Occupational exposure to extremely low-frequency magnetic fields and follicular lymphoma risk: a family case-control study.
Odutola MK, van Leeuwen MT, Bruinsma FJ, Benke G, Turner MC, Trotman J, Turner J, Seymour JF, Prince HM, Milliken ST, Tiley C, Hertzberg M, Roncolato F, Opat S, Lindeman R, Verner E, Underhill CR, Cardis E, Giles G, Vajdic CM
Occup Environ Med, 80(10):599-602, 18 Sep 2023
Cited by: 0 articles | PMID: 37722828 | PMCID: PMC10591762
Add to export list Free full text in Europe PMC
Patterns of care for people with small cell lung cancer in Victoria, 2011-19: a retrospective, population-based registry data study.
Huang J, Faisal W, Brand M, Smith S, Alexander M, Briggs L, Conron M, Duffy M, John T, Langton D, Lesage J, MacManus M, Mitchell P, Olesen I, Parente P, Philip J, Samuel E, Torres J, Underhill CR, [...] Stirling R
Med J Aust, 219(3):120-126, 26 Jun 2023
Cited by: 2 articles | PMID: 37365486
Add to export list
Workforce challenges across Victorian oncology services: author reply.
Collins IM, Blum R, Segelov E, Parente P, Underhill C
Intern Med J, 53(6):1094, 01 Jun 2023
Cited by: 0 articles | PMID: 37349277
Add to export list
Testosterone suppression plus enzalutamide versus testosterone suppression plus standard antiandrogen therapy for metastatic hormone-sensitive prostate cancer (ENZAMET): an international, open-label, randomised, phase 3 trial.
Sweeney CJ, Martin AJ, Stockler MR, Begbie S, Cheung L, Chi KN, Chowdhury S, Frydenberg M, Horvath LG, Joshua AM, Lawrence NJ, Marx G, McCaffrey J, McDermott R, McJannett M, North SA, Parnis F, Parulekar W, Pook DW, [...] ENZAMET trial investigators and Australian and New Zealand Urogenital and Prostate Cancer Trials Group
Lancet Oncol, 24(4):323-334, 01 Apr 2023
Cited by: 39 articles | PMID: 36990608
Add to export list
Is there a role for combined anti-PD-1/CTLA-4 checkpoint blockade in the management of advanced biliary tract cancers?
Klein O, Kee D, Nagrial A, Markman B, Underhill C, Michael M, Behren A, Palmer J, Tebbutt NC, Carlino MS, Cebon J
Cancer, 129(7):1129-1130, 24 Jan 2023
Cited by: 0 articles | PMID: 36692958
Add to export list
Workforce challenges across Victorian medical oncology services.
Collins IM, Blum R, Segelov E, Parente P, Underhill C
Intern Med J, 53(6):946-950, 04 Jan 2023
Cited by: 0 articles | PMID: 36571397
Add to export list
SARS-CoV-2 Seroprevalence in a Cohort of International Travellers Returning to Rural Australia: Enablers and Barriers to Containment of COVID-19.
Jackson J, Chan C, McBurnie J, La Hera-Fuentes G, Burston J, Bridges L, Underhill C, Eek R, Hueston L, O'Sullivan M, Dwyer DE
Aust N Z J Public Health, 47(1):100003, 19 Jan 2023
Cited by: 0 articles | PMID: 36680916 | PMCID: PMC9851405
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC

1-25 of 298 results

1 2 3 Next ...

Search life-sciences literature (45,100,050 articles, preprints and more)

Search results

Partnerships & funding